daily oral glp-1 receptor agonist orforglipron for adults with obesity FDA approves Foundayo, an alternative to Wegovy and Ozempic Orforglipron is the first FDA-approved
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


























